Molecule Details
| InChIKey | VZCOCGXPISHVHC-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2-[Bis[2-[carboxymethyl-[2-oxo-2-[(5-sulfamoyl-2,5-dihydro-1,3,4-thiadiazol-2-yl)amino]ethyl]amino]ethyl]amino]acetic acid |
| Canonical SMILES | NS(=O)(=O)C1N=NC(NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)NC2N=NC(S(N)(=O)=O)S2)CC(=O)O)CC(=O)O)S1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.43 |
| Source | ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile